Aristotle University Of Thessaloniki (AUTH)
Efficacy and safety of mydriatic microdrops compared with standard drops for retinopathy of prematurity screening
Abstract
dc:descriptionBackground: Mydriatic regimens used in retinopathy of prematurity (ROP) screening vary considerably and are usually unnecessarily overdosed, thus subjecting this fragile population to a higher risk of systemic complications. The reduction of mydriatic drop volume has emerged as a promising administration technique for achieving adequate mydriasis while minimizing systemic adverse events (AE).Aims: To examine whether microdrops (6.5 μl) of phenylephrine 1.67% and tropicamide 0.33% are non-inferior to standard drops (28-34 μl) regarding mydriatic efficacy at 45minutes (T45) (primary outcome), T90 and T120 (secondary outcomes). The occurrence of systemic AE and systemic absorption of phenylephrine were additional secondary outcomes. Methods: A double-masked non-inferiority crossover randomized controlled trial was conducted from September 2021–January 2023, at a tertiary center in Northern Greece. Eligible preterm infants received either standard drops, administered through the commercially available plastic multidose dropper bottle, or microdrops, administered via a micropipette, (1-drop, 3-doses, 5-minute-interval) at a random allocation sequence (S/M and M/S group) with sufficient washout period. The horizontal pupil diameter in either eye was measured by a masked observer using a customized ruler in 0.5 mm increments at T45, T90, T120. Mixed-effects linear regression models were developed, and the 95% confidence interval (CI) approach was used for assessing non-inferiority, after Bonferroni multiplicity adjustment. The pre-defined non-inferiority margin was -0.4 mm. Heart rate, oxygen saturation, blood pressure measurements at T45, T90, T120, 24-hour hypertensive episodes, 48-hour systemic AE were assessed. Sparse whole blood samples were analyzed using Hydrophilic Interaction Liquid Chromatography – tandem mass spectrometry (HILIC–MS/MS) for determining phenylephrine blood concentration at nine time points within 3-hours from mydriasis. Pooled pharmacokinetic parameters were calculated based on a mathematical model developed. Results: Ninety-seven infants underwent ROP screening during our study period. Fourteen were excluded. Eighty-three were randomized (42 in S/M, 41 in M/S group). Mean gestational age was 29.7 weeks, mean birth weight was 1277 grams. Mean (standard deviation) pupil diameter was 6.17 (0.39) mm and 6.05 (0.39) mm at T45, 6.09 (0.54) mm and 6.06 (0.54) mm at T90, 5.73 (0.63) mm and 5.76 (0.63) mm at T120, after microdrops and standard drops, respectively (Bonferroni corrected 95%CI at T45: 0.01, 0.23; T90: -0.10, 0.17; T120: -0.18, 0.14). Based on the Bonferroni corrected 95%CI, microdrops were shown to be superior regarding mydriatic efficacy at T45, and non-inferior regarding mydriatic efficacy at T90 and T120, compared with standard drops. Lower levels of oxygen saturation at T45, T90, and higher percentage of 24-hour hypertensive episodes were observed after standard drops (p < 0.05). A one compartment model with first order absorption best described the data. Phenylephrine’s half-life was 53 minutes, apparent volume of distribution of microdrops was 31.8L, relative bioavailability of standard drops compared to microdrops was 16%, first order absorption rate constant was 0.03 min-1 for microdrops and 0.064 min-1 for standard drops. Conclusions: Non-inferiority of microdrops compared with standard drops of a diluted mixture regarding mydriatic efficacy at T45, T90, T120 was established, and fewer systemic AE after microdrops were shown. This is the first study determining the pharmacokinetic profile of phenylephrine eyedrops in preterm infants.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Seliniotaki, Aikaterini
- Σεληνιωτάκη, Αικατερίνη
Subjects
dc:subject × 24- Μυδρίαση
- Μικροσταγόνες
- Οφθαλμικά κολλύρια
- Φαρμακοκινητική
- Φαινυλεφρίνη
- Πρόωρα νεογνά
- Τροπικαμίδη
- Eyedrops
- Mydriasis
- Microdrops
- Ocular drugs
- Pharmacokinetics
- Phenylephrine
- Preterm infants
- Pupil dilation
- Tropicamide
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Οφθαλμολογία
- Παιδιατρική, Νεογνολογία και Υγεία του παιδιού
- Clinical Medicine
- Medical and Health Sciences
- Ophthalmology
- Pediatrics, Perinatology and Child Health
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57818